Literature DB >> 15319461

Effects of dietary cholesterol on plasma lipoproteins in Smith-Lemli-Opitz syndrome.

Louise S Merkens1, William E Connor, Leesa M Linck, Don S Lin, Donna P Flavell, Robert D Steiner.   

Abstract

Smith-Lemli-Opitz syndrome is a condition of impaired cholesterol synthesis that is caused by mutations in DHCR7 encoding 7-dehydrocholesterol-Delta7 reductase. Birth defects and mental retardation are characteristic. Deficient plasma and tissue cholesterol and excess cholesterol precursors 7 and 8 dehydrocholesterol (7DHC and 8DHC) contribute to the pathogenesis. Cholesterol is transported to tissues via lipoproteins. We measured the effect of dietary cholesterol (egg yolk) on plasma lipoproteins to evaluate this potential treatment. We used the enzymatic method to measure total sterols in lipoproteins (n=12) and plasma (n=16). In addition, we analyzed individual plasma sterols by a gas chromatographic method. Samples were evaluated after 3 wk of a cholesterol-free diet and after 6-19 mo of dietary cholesterol. We also analyzed the distribution of sterols in lipoproteins and the apolipoprotein E genotype. Dietary cholesterol significantly increased the total sterols in plasma (2.22 +/- 0.13 to 3.10 +/- 0.22; mean +/- SEM; p < 0.002), in LDL (0.98 +/- 0.13 to 1.52 +/- 0.17 mM), and in HDL (0.72 +/- 0.04 to 0.92 +/- 0.07). Plasma cholesterol increased (1.78 +/- 0.16 to 2.67 +/- 0.25 mM; p < 0.007) and plasma 7DHC decreased in 10 children, but the mean decrease was not significant. The distribution of individual sterols in each lipoprotein fraction was similar to the distribution in plasma. The baseline cholesterol and the response to dietary cholesterol was the same in children with 3/3 and 3/4 apolipoprotein E genotypes. Dietary cholesterol increased total sterols in plasma, LDL, and HDL in children with Smith-Lemli-Opitz syndrome. These favorable increases in the lipoproteins are potentially therapeutic for this condition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15319461     DOI: 10.1203/01.PDR.0000141522.14177.4F

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  11 in total

1.  In Memoriam: William E. Connor (1921-2009).

Authors:  Shailendra B Patel; Robert D Steiner
Journal:  J Lipid Res       Date:  2010-04       Impact factor: 5.922

Review 2.  Recent insights into the Smith-Lemli-Opitz syndrome.

Authors:  H Yu; S B Patel
Journal:  Clin Genet       Date:  2005-11       Impact factor: 4.438

3.  A Pilot Study of the Association of Markers of Cholesterol Synthesis with Disturbed Sleep in Smith-Lemli-Opitz Syndrome.

Authors:  Kurt A Freeman; Erin Olufs; Megan Tudor; Jean-Baptiste Roullet; Robert D Steiner
Journal:  J Dev Behav Pediatr       Date:  2016-06       Impact factor: 2.225

4.  No evidence for mevalonate shunting in moderately affected children with Smith-Lemli-Opitz syndrome.

Authors:  Jean-Baptiste Roullet; Louise S Merkens; Anuradha S Pappu; Megan D Jacobs; Rolf Winter; William E Connor; Robert D Steiner
Journal:  J Inherit Metab Dis       Date:  2012-03-06       Impact factor: 4.982

5.  Detoxification of 7-dehydrocholesterol fatal to Helicobacter pylori is a novel role of cholesterol glucosylation.

Authors:  Hirofumi Shimomura; Kouichi Hosoda; David J McGee; Shunji Hayashi; Kenji Yokota; Yoshikazu Hirai
Journal:  J Bacteriol       Date:  2012-11-09       Impact factor: 3.490

6.  Severe facial clefting in Insig-deficient mouse embryos caused by sterol accumulation and reversed by lovastatin.

Authors:  Luke J Engelking; Bret M Evers; James A Richardson; Joseph L Goldstein; Michael S Brown; Guosheng Liang
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

7.  Challenging behavior in Smith-Lemli-Opitz syndrome: initial test of biobehavioral influences.

Authors:  Kurt A Freeman; Rose Eagle; Louise S Merkens; Darryn Sikora; Kersti Pettit-Kekel; Mina Nguyen-Driver; Robert D Steiner
Journal:  Cogn Behav Neurol       Date:  2013-03       Impact factor: 1.600

8.  Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

Authors:  Katie T Jenkins; Louise S Merkens; Matthew R Tubb; Leslie Myatt; W Sean Davidson; Robert D Steiner; Laura A Woollett
Journal:  Mol Genet Metab       Date:  2008-03-17       Impact factor: 4.797

9.  Plasma plant sterol levels do not reflect cholesterol absorption in children with Smith-Lemli-Opitz syndrome.

Authors:  Louise S Merkens; Julia M Jordan; Jennifer A Penfield; Dieter Lütjohann; William E Connor; Robert D Steiner
Journal:  J Pediatr       Date:  2008-12-21       Impact factor: 4.406

10.  A placebo-controlled trial of simvastatin therapy in Smith-Lemli-Opitz syndrome.

Authors:  Christopher A Wassif; Lisa Kratz; Susan E Sparks; Courtney Wheeler; Simona Bianconi; Andrea Gropman; Karim A Calis; Richard I Kelley; Elaine Tierney; Forbes D Porter
Journal:  Genet Med       Date:  2016-08-11       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.